JDRF Blog

Latest in Glucose control

  • Proof-of-Concept for Hypoglycemia Prevention

    June 5, 2019

    Hypoglycemia, or low blood sugar, can have serious effects, and it is, for most people with type 1 diabetes (T1D), the most...

  • Can a Snail Hold the Key to Better Blood Sugar Control?

    February 26, 2019

    “Rapid-acting” insulin analogs were introduced commercially in the 1990s; however, these insulins are still slower than insulin secreted from a nondiabetic pancreas,...

  • SGLT Inhibition: It’s Not Just for Type 2 Anymore

    February 8, 2019

    SGLT inhibition may soon be approved for use for people with type 1 diabetes Can a drug long-used for type 2 diabetes,...

  • Maybe it’ll Work for Type 1: Clinical Trial Results Announced

    February 1, 2019

    A protein, called glucokinase (or GK), acts as a key regulator of sugar levels in the body, and its expression is limited to tissues that require sugar-sensing, mainly the liver and pancreatic beta cells. If blood glucose levels are deemed too high, activation of GK in the liver increases glucose utilization which in turn lowers blood glucose.

  • JDRF Drives Next-Generation Type 1 Diabetes Research With New Partnerships & Breakthrough Science

    December 22, 2018

    JDRF, the leading global organization funding type 1 diabetes (T1D) research, announced today that it made progressive advances this year on its...

  • Low Blood Sugar, and the Hope to Save Lives

    August 21, 2018

    Candace Reno, Ph.D., is studying hypoglycemia, or low blood sugar, and the mechanisms by which it can be lethal. When she’s not...

  • JDRF Top Advances Over the Past Year

    July 5, 2018

    At JDRF, we are committed to funding the development of new therapies to keep people with type 1 diabetes (T1D) healthier, longer,...

  • JDRF’s Leadership Role: Top-Line Research at ADA’s Scientific Sessions

    June 29, 2018

    People with type 1 diabetes (T1D) have to live with it 24 hours a day, 7 days a week, 365 days a...